Table 3.
OR | 95% CI lower, upper |
P-value | |
---|---|---|---|
| |||
HRV (time domain) | |||
| |||
Mean heart rate (bpm) | 1.023 | 1.004, 1.043 | 0.019 |
SDNN (ms) | 1.008 | 1.003, 1.013 | 0.002 |
rMSSD (ms) | 1.003 | 0.999, 1.006 | 0.189 |
pNN20, % | 0.999 | 0.990, 1.007 | 0.734 |
pNN50, % | 1.000 | 0.989, 1.012 | 0.984 |
| |||
HRV (frequency domain) | |||
| |||
LF nu | 5.210 | 1.433, 18.942 | 0.012 |
LF (ms2) | 1.000 | 0.999, 1.000 | 0.126 |
HF nu | 0.192 | 0.053, 0.698 | 0.012 |
HF (ms2) | 1.000 | 0.999, 1.000 | 0.301 |
LF/HF ratio | 1.083 | 0.996, 1.177 | 0.062 |
Analysis adjusted by age, sex, race/ethnicity, smoking status; BMI; HTN, DM, bb, and any ccb. OSA= obstructive sleep apnea; OR= odds ratio; CI= confidence interval; HRV= heart rate variability; NN= normal-to-normal intervals; SDNN= the standard deviation of NN intervals; rMSSD= the square root of the mean of the squares of the successive differences between adjacent NN intervals; pNN20= the percentage of absolute differences in successive NN values >20ms; pNN50= the percentage of absolute differences in successive NN values >50ms; LF= low frequency power (between 0.04 to 0.15 Hz); HF= high frequency power (between 0.15 to 0.4 Hz); nu= normalized units; ms= milliseconds. BMI= body mass index; HTN= hypertension; DM= Diabetes Mellitus, bb= beta-blocker; ccb= calcium channel blocker;